SteelPeak Wealth LLC Acquires Shares of 14,271 Omnicell, Inc. (NASDAQ:OMCL)

SteelPeak Wealth LLC bought a new position in Omnicell, Inc. (NASDAQ:OMCL) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 14,271 shares of the company’s stock, valued at approximately $635,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. GAMMA Investing LLC grew its holdings in Omnicell by 78.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock worth $55,000 after acquiring an additional 553 shares during the period. Curi RMB Capital LLC boosted its position in shares of Omnicell by 0.7% in the 3rd quarter. Curi RMB Capital LLC now owns 88,815 shares of the company’s stock worth $3,872,000 after purchasing an additional 651 shares during the last quarter. KBC Group NV grew its stake in shares of Omnicell by 60.8% during the fourth quarter. KBC Group NV now owns 2,057 shares of the company’s stock worth $92,000 after purchasing an additional 778 shares during the period. The Manufacturers Life Insurance Company increased its holdings in Omnicell by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 23,459 shares of the company’s stock valued at $635,000 after purchasing an additional 1,360 shares during the last quarter. Finally, 1620 Investment Advisors Inc. lifted its stake in Omnicell by 230.1% in the third quarter. 1620 Investment Advisors Inc. now owns 2,212 shares of the company’s stock valued at $96,000 after buying an additional 1,542 shares during the period. Institutional investors own 97.70% of the company’s stock.

Omnicell Price Performance

OMCL opened at $45.31 on Friday. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of -116.18, a P/E/G ratio of 29.73 and a beta of 0.78. The business’s 50-day moving average price is $44.68 and its two-hundred day moving average price is $42.64. Omnicell, Inc. has a 1 year low of $25.12 and a 1 year high of $55.74.

Insider Activity at Omnicell

In other news, Director Mark W. Parrish sold 12,000 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $47.30, for a total value of $567,600.00. Following the sale, the director now owns 58,427 shares of the company’s stock, valued at $2,763,597.10. The trade was a 17.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.64% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on OMCL. StockNews.com cut Omnicell from a “buy” rating to a “hold” rating in a research note on Tuesday, December 10th. JPMorgan Chase & Co. upped their target price on shares of Omnicell from $37.00 to $44.00 and gave the company a “neutral” rating in a research note on Thursday, November 21st. Barclays lifted their price target on shares of Omnicell from $39.00 to $58.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Wells Fargo & Company decreased their target price on Omnicell from $49.00 to $40.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. Finally, Craig Hallum raised their price target on Omnicell from $45.00 to $64.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $50.00.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.